Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance

doi:10.3748/wjg.v18.i8.840

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10729)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

814

HTML

9424

Figures (1-4)

311

Tables (1-2)

180

Sum=10729

Feb 28, 2012 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (132)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 28, 2012; 18(8): 840-846
Published online Feb 28, 2012. doi: 10.3748/wjg.v18.i8.840

Full Size Figure Download Figure

Figure 4 Kaplan-Meier survival curves of pancreatic ductal adenocarcinoma patients. The prognosis was significantly worse in the fibroblast activation protein (FAP)-positive group compared with the FAP-negative group (P = 0.0085).

Citation: Shi M, Yu DH, Chen Y, Zhao CY, Zhang J, Liu QH, Ni CR, Zhu MH. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol 2012; 18(8): 840-846
URL: https://www.wjgnet.com/1007-9327/full/v18/i8/840.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i8.840